Scott Sweazy
Urology · West Columbia, SCNPI 1750319935
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Coloplast at 30.5% of the total. Reporting peaked in 2019 at $3,080 and has fallen 99.3% since, to $21 in 2025.
Across 230 payments — averaging $33.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$2K
- BK Medical Holding Company Inc.$2K
- Teleflex LLC$610
- Medtronic$494
- Neotract Inc.$476
- Astellas Pharma US Inc$290
- plus $2K from 27 others
What the payments were for
- Consulting fees$1,50019%
- Travel & lodging$1,77523%
- Food & beverage$4,46858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 66 | $2,364 |
| BK Medical Holding Company Inc. | 1 | $1,500 |
| Teleflex LLC | 10 | $610 |
| Medtronic(2 entities) | 16 | $494 |
| Neotract Inc. | 8 | $476 |
| Astellas Pharma US Inc | 18 | $290 |
| Johnson & Johnson | 14 | $249 |
| Procept Biorobotics Corporation | 2 | $233 |
| AbbVie(2 entities) | 12 | $221 |
| Boston Scientific | 8 | $173 |
| Zyla Life Sciences, Inc. | 22 | $126 |
| Pfizer | 8 | $117 |
| Tactile Systems Technology Inc | 5 | $114 |
| Tolmar Pharmaceuticals, Inc. | 4 | $82 |
| Axonics, Inc. | 3 | $74 |
| Novartis | 4 | $70 |
| Blue Earth Diagnostics | 3 | $61 |
| Myriad Genetic Laboratories, Inc. | 3 | $54 |
| Urogen Pharma, Inc. | 3 | $47 |
| Endo Pharmaceuticals Inc. | 3 | $46 |
| Organogenesis Inc. | 1 | $46 |
| Mission Pharmacal Company | 3 | $43 |
| Convatec Inc. | 1 | $40 |
| Urovant Sciences Inc | 2 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| Antares Pharma, Inc. | 2 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Inari Medical, Inc. | 1 | $23 |
| Bard Peripheral Vascular, Inc. | 1 | $21 |
| Endo USA, Inc. | 1 | $19 |
| Bayer | 1 | $13 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $12 |
| Clarus Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$1,433
- UroLift System$531
- UroLift$401
- ClosureFast$158
- AquaBeam Robotic System$144
- INTERSTIM$101
How this compares
$7,743 in reported general payments places this provider in the 75th percentile of 196 urology providers in South Carolina.
Other urology in West Columbia
- Phillip WestbrookWest Columbia$14K
- Griffin MorrissonWest Columbia$14K
- Thomas WillardWest Columbia$12K
- Keith BrightbillWest Columbia$12K
- John BeasleyWest Columbia$8K
- David LambWest Columbia$7K
- Neal ShoreMyrtle Beach$3.2M
- Manish PatelElgin$213K
- Sandip PrasadCharleston$177K
- Benjamin DropkinGreenville$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.